Regeneron Deal History & Licensing Activity

About Regeneron Licensing & Deal Activity

Regeneron is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 13 deals over the past three years, Regeneron ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Regeneron include Oncology (16 deals and trials), Solid Tumors (14 deals and trials), Hematological Malignancies (8 deals and trials), and Cardiovascular (7 deals and trials). In terms of modality, Regeneron has shown particular interest in radiopharmaceuticals, bispecific antibodies, antibodies.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Regeneron and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Regeneron's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.